The launch of retatrutide, a innovative medication for weight management, has naturally sparked significant interest regarding its expense. Currently, the publicly released information regarding the exact retail value of retatrutide. However, analysts suggest that it will likely be in line with other modern GLP-1 receptor agonists like semaglutide